- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2015-005437-53.
Displaying page 1 of 1.
EudraCT Number: 2015-005437-53 | Sponsor Protocol Number: ITCC053 | Start Date*: 2016-11-03 |
Sponsor Name:Erasmus Medical Center | ||
Full Title: A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies Study ITCC 053 | ||
Medical condition: Malignancies carrying a genetic alteration of ALK, MET or ROS1 | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Restarted) DE (Ongoing) IE (Completed) ES (Ongoing) DK (Ongoing) IT (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
